A Prospective Study to Evaluate the Relationship Between Serum Drug Concentrations, Presence of Anti-Drug Antibodies (ADAs), Therapeutic Efficacy and to Reveal the Optimal Use of Adalimumab and Infliximab for the Treatment of Plaque Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 02 Dec 2015 New trial record